市场调查报告书
商品编码
1609826
2024-2032 年日本辅助生殖技术市场报告(按产品、类型(体外受精、人工授精)、最终用途和地区)Japan Assisted Reproductive Technology Market Report by Product, Type (In-Vitro Fertilization, Artificial Insemination), End Use, and Region 2024-2032 |
2023年日本辅助生殖技术市场规模达32.941IMARC Group美元。日本不孕症的盛行率不断上升、政府采取的支持措施、辅助生殖技术的最新技术进步以及社会对不孕症治疗的认识和接受度不断提高,是推动市场发展的一些关键因素。
辅助生殖技术(ART)是指主要用于解决不孕症的医疗程序。它包括多种方法,例如体外受精 (IVF)、胞浆内单一精子注射 (ICSI)、配子或胚胎冷冻保存以及生育药物。 ART 具有多种功能,例如能够绕过受精的生理障碍、提高配子品质或保持生育力。它由医学专业知识、先进的实验室、法律框架和道德治理组成。 ART 被不孕夫妇、单身人士以及渴望为人父母的男女同性恋群体广泛使用。它也可应用于遗传性疾病预防、家庭平衡、代孕便利性和癌症患者的生育力保存。 ART 提供了更高的受孕机会、控制时间、筛检遗传疾病的可能性以及增加对生育能力的了解。除此之外,它还提供了几个优点,例如多次怀孕尝试的选择以及允许同性伴侣或单亲父母怀孕。
由于生活方式的改变和老年人口的增加,日本不孕症的盛行率日益增加,这是推动市场成长的关键因素之一。此外,政府推出的支持措施,例如补贴 ART 程序以鼓励夫妻寻求治疗,正在推动市场成长。除此之外,ART 的最新技术进步提高了成功率,从而促进了其采用,从而促进了市场的成长。此外,人们对不孕症治疗的认识和社会接受度不断提高,也促进了市场的成长。此外,监管框架的不断完善为潜在患者提供了安全保证,正在推动市场成长。除此之外,日本可支配收入的增加,使更多的人能够负担得起通常昂贵的治疗方法,例如抗逆转录病毒治疗,这也推动了市场的成长。此外,主要参与者不断增加对研究和创新的投资,以开发有效的不孕症治疗方案,这对市场成长产生了积极影响。同时,日本和国际生育诊所之间不断加强的合作,以扩大获得最佳实践和先进治疗的机会,并正在支持市场的成长。与此一致的是,日本文化中日益增长的社会压力和对创建家庭的渴望正在推动市场的成长。此外,生育旅游的出现,让人们可以前往日本寻求高品质的辅助生殖服务,也刺激了市场的成长。此外,ART 服务扩展到更广泛的人群,包括老年妇女和单身人士,这开闢了新的细分市场,正在加速市场成长。除此之外,基因筛检技术的最新进展使 ART 更安全、更可靠,从而加强了全国市场的成长。
市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外,也提供了所有主要公司的详细资料。
Japan assisted reproductive technology market size reached US$ 3,294.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,056.1 Million by 2032, exhibiting a growth rate (CAGR) of 7.00% during 2024-2032. The increasing prevalence of infertility in Japan, introduction of supportive measures by the government, recent technological advancements in ART, and rising awareness and societal acceptance of infertility treatment represent some of the key factors driving the market.
Assisted reproductive technology (ART) refers to medical procedures used primarily to address infertility. It includes a variety of methodologies, such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and fertility medication. ART possesses several features, like the ability to bypass physiological hurdles to fertilization, enhance gamete quality, or preserve fertility. It is comprised of medical expertise, sophisticated laboratories, legal frameworks, and ethical governance. ART is widely used by infertile couples, single individuals, and the lesbian and gay community desiring parenthood. It also finds applications in genetic disorder prevention, family balancing, surrogacy facilitation, and fertility preservation for cancer patients. ART offers a higher chance of conception, control over timing, the possibility of screening for genetic diseases, and increased knowledge about one's fertility. In addition to this, it provides several advantages, such as options for multiple pregnancy attempts and allowing same-sex couples or single parents to conceive.
The increasing prevalence of infertility in Japan due to lifestyle changes and the rising geriatric population represents one of the key factors propelling the market growth. Additionally, the introduction of supportive measures by the government, such as subsidizing ART procedures to encourage couples to seek treatment, is boosting the market growth. Besides this, recent technological advancements in ART that are enhancing success rates, thus boosting its adoption, are catalyzing the market growth. Furthermore, the rising awareness and social acceptance of infertility treatments are contributing to the market growth. In addition, the ongoing improvements in the regulatory framework, which provide safety assurances to potential patients, are driving the market growth. Apart from this, the increasing disposable incomes in Japan, allowing more individuals to afford often expensive treatments, such as ART, is bolstering the market growth. Moreover, the escalating investment in research and innovation by key players to develop effective treatment options for infertility is positively influencing the market growth. Along with this, the rising collaborations between Japanese and international fertility clinics to expand access to best practices and advanced treatments are supporting the market growth. In line with this, the increasing societal pressure and desire for family creation in Japan's culture is fueling the market growth. Additionally, the emergence of fertility tourism, allowing people to visit Japan for high-quality ART services, is stimulating the market growth. Furthermore, the extension of ART services to a broader demographic, including older women and single individuals, which is opening new segments, is accelerating the market growth. Besides this, recent advancements in genetic screening technologies that are making ART safer and more reliable are strengthening the market growth across the country.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.